EP 1572079 A4 20060906 - MAMMALIAN CDR MIMETIBODIES, COMPOSITIONS, METHODS AND USES
Title (en)
MAMMALIAN CDR MIMETIBODIES, COMPOSITIONS, METHODS AND USES
Title (de)
SÄUGETIER-CDR-MIMETIKÖRPER, ZUSAMMENSETZUNGEN, VERFAHREN UND ANWENDUNGSZWECKE
Title (fr)
CORPS MIMETIQUES DE CDR DE MAMMIFERE, COMPOSITIONS, PROCEDES ET UTILISATIONS
Publication
Application
Priority
- US 0309139 W 20030324
- US 36879102 P 20020329
Abstract (en)
[origin: WO03084477A2] The present invention relates to at least one novel EPO human CDR mimetibody or specified portion or variant, including isolated nucleic acids that encode at least one CDR mimetibody or specified portion or variant, CDR mimetibody or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
IPC 1-7
IPC 8 full level
C07K 14/505 (2006.01); C07K 14/52 (2006.01); C07K 16/00 (2006.01)
CPC (source: EP)
C07K 14/505 (2013.01); C07K 14/524 (2013.01); C07K 16/00 (2013.01); C07K 2318/10 (2013.01)
Citation (search report)
- [E] WO 2004002417 A2 20040108 - CENTOCOR INC [US]
- [A] BEREZOV A ET AL: "Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysis.", JOURNAL OF MEDICINAL CHEMISTRY. 2 AUG 2001, vol. 44, no. 16, 2 August 2001 (2001-08-02), pages 2565 - 2574, XP002390205, ISSN: 0022-2623
- See references of WO 03084477A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03084477 A2 20031016; WO 03084477 A3 20050909; AU 2003222069 A1 20031020; AU 2003222069 A8 20031020; EP 1572079 A2 20050914; EP 1572079 A4 20060906
DOCDB simple family (application)
US 0309139 W 20030324; AU 2003222069 A 20030324; EP 03718053 A 20030324